Proanthocyanidins Market Report 2026

The proanthocyanidins market size has grown strongly in recent years. It will grow from $2.85 billion in 2025 to $3.12 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to rising consumer awareness of antioxidant benefits, increased use in cardiovascular health products, expansion of herbal supplement markets, availability of diverse botanical sources, growing use in nutraceutical formulations.

The proanthocyanidins market size is expected to see rapid growth in the next few years. It will grow to $4.66 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for plant-based health supplements, rising integration into functional beverages, expansion of anti-aging personal care products, growing investments in natural ingredient extraction, increasing scientific validation of polyphenol benefits. Major trends in the forecast period include growing demand for natural antioxidant ingredients, rising use in dietary supplements, expansion of functional food applications, increasing adoption in personal care products, enhanced focus on plant-based bioactives.

The rising prevalence of lifestyle-related diseases is expected to drive the growth of the proanthocyanidin market going forward. Lifestyle-related diseases include conditions such as cardiovascular disease, stroke, diabetes, and certain cancers that are closely linked to modern lifestyle habits. Proanthocyanidins help protect the heart and circulatory system by acting as antioxidants that inhibit the formation of harmful nitrosamines. As a result, the increasing burden of lifestyle diseases is boosting demand for proanthocyanidins. For instance, in March 2024, the National Library of Medicine, a US-based medical library, projected that global diabetes cases will increase to 783 million by 2045. Therefore, the growing prevalence of lifestyle-related diseases is supporting the expansion of the proanthocyanidin market.

Product innovation is a significant trend gaining traction in the proanthocyanidins market. Leading companies in this sector are concentrating on developing new products to maintain their market presence. For example, in January 2024, Theralogix, a Maryland-based company known for its scientifically formulated nutritional supplements, introduced Mannose One, a new dietary supplement designed to enhance urinary tract health. Theralogix developed Mannose One to support urinary tract health and help prevent urinary tract infections (UTIs) through the inclusion of d-mannose. This dietary supplement provides 2,000 mg of d-mannose per serving, a research-supported dosage that helps prevent bacterial adhesion and flush bacteria from the urinary tract.

In February 2023, Groupe Berkem, a France-based company dedicated to integrating plant-based chemistry across various sectors, including health, beauty, and nutrition, acquired i.Bioceuticals for an undisclosed sum. This strategic acquisition aims to enhance Groupe Berkem's internationalization efforts while staying true to its mission of providing sustainable, bio-based solutions. i.Bioceuticals is a US-based firm that acts as the exclusive North American distributor of nutritional supplements from the Dutch company INC (International Nutrition Company) and focuses on supplying antioxidant active ingredients to the market.

Major companies operating in the proanthocyanidins market are Amway Corp., Herbalife Nutrition Ltd., Ocean Spray Cranberries Inc., Nature's Way Limited, Naturex SA, NOW Foods Private Limited, Swanson Group, Nexira SAS, Natrol LLC, Life Extension, Indena S.p.A., Nutramax Laboratories Private Limited, Jarrow Formulas Inc., Gaia Herbs Inc., Fruit d'Or Inc., Solgar Vitamin & Herb Company Inc., Bluebonnet Nutrition Corporation, Doctor's Best Inc., Reserveage Organics, Eevia Health Oy, Natac Group, Himalaya Food International Ltd., Douglas Laboratories Corp., Biotivia LLC, Puritan's Pride Inc., Skin Actives Scientific LLC, Source Naturals Inc., Terry Naturally, Advanced Functional Nutrition Inc., Xian Yuensun Biological Technology Co. Ltd.

North America was the largest region in the proanthocyanidins market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proanthocyanidins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the proanthocyanidins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The proanthocyanidin market consists of sales of oligomeric proanthocyanidins, flavonoids, polyphenols, condensed tannins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.